Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Can Florida's First Needle Exchange Help Curb HIV?

The state leads the nation in new diagnoses, and close to six percent are attributed to injection-drug users sharing used or infected needles.

Published
4 hours ago
From
The Atlantic
Ukraine signs amicable agreement with Gilead on hepatitis C drug

Ukraine has signed an amicable agreement with U.S. Gilead Sciences, Inc. biopharmaceutical company on the Sovaldi medicine used to treat chronic hepatitis C infection in adults, acting Ukrainian Health Minister Ulana Suprun said at a press conference on Wednesday. The whole course of hepatitis C treatment with the use of Sovaldi in Ukraine will cost about $750.

Published
4 hours ago
From
Interfax Ukraine
What we know about the new England PrEP trial

@teamPrEPster, and other HIV advocate groups, will be keeping a watchful eye on development of the trial, not least to ensure that there are no further delays to its implementation.

Published
7 hours ago
From
Prepster
Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have

Published
8 hours ago
By
Liz Highleyman
Meet The Man Who Stopped Thousands Of People Becoming HIV-Positive

“I knew I was doing something of substance, but it’s really overwhelming.” In an exclusive interview with BuzzFeed News, Greg Owen reveals the story behind Britain’s largest ever drop in HIV transmissions.

Published
26 February 2017
From
BuzzFeed News
Didier Lestrade: My First 30 Years with HIV

French HIV/AIDS activist Didier Lestrade reflects on a lifetime spent fighting the epidemic, in both public and private.

Published
26 February 2017
From
Vice
Egypt targets hepatitis C patients for medical tourism

In mid 2016, Prime Pharma, a private Egyptian pharmaceutical company, launched Tour n’ Cure to revive therapeutic tourism in Egypt. The first target is hepatitis C patients from around the world. Countries targeted are Spain, Belgium, Italy, Netherlands and the UK.

Published
24 February 2017
From
International Medical Tourism Journal
HIV-positive kidney failure patients face greater hurdles in receiving necessary transplants

A new study finds that HIV-infected individuals with kidney failure are less likely to receive a kidney transplant — especially from living donors — than their uninfected counterparts.

Published
24 February 2017
From
University of Alabama Birmingham press release
Bacterial vaginosis does not affect efficacy of oral PrEP in women

Research presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) found that the efficacy of oral pre-exposure prophylaxis (PrEP) for women was not affected

Published
23 February 2017
By
Gus Cairns
Report highlights sexual health barriers for gay Asian men in New South Wales

The research shows that sexual practices among gay Asian men in Sydney have changed over recent years. Rates of condomless intercourse with casual partners have increased to 37 per cent from 14 per cent in 2002, now on par with the general gay community. ACON call for effective strategies to enhance HIV prevention and education in the community.

Published
23 February 2017
From
Star Observer
← First12345...2229Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.